Financial Management Professionals’s iShares Biotechnology ETF IBB Stock Holding History

Financial Management Professionals’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3	Closed	–	–	1005
2023 Q1	$0	Hold	3	–	–	﹤0.01%	1066
2022 Q4	$0	Hold	3	–	–	﹤0.01%	994
2022 Q3	$0	Hold	3	–	–	﹤0.01%	1005
2022 Q2	$0	Hold	3	–	–	﹤0.01%	1020
2022 Q1	$0	Hold	3	–	–	﹤0.01%	1081
2021 Q4	$0	Buy	+3	New	+$464	﹤0.01%	1017
2020 Q4	–	Sell	-78	Closed	-$11K	–	650
2020 Q3	$11K	Buy	+78	New	+$10.6K	﹤0.01%	305
2015 Q1	–	Sell	-714	Closed	-$72K	–	288
2014 Q4	$72K	Hold	714	–	–	0.04%	71
2014 Q3	$65K	Hold	714	–	–	0.04%	73
2014 Q2	$61K	Sell	714 -44,886	-98%	-$3.54M	0.04%	76
2014 Q1	$3.59M	Sell	45,600 -534	-1%	-$44.5K	2.47%	12
2013 Q4	$3.49M	Sell	46,134 -579	-1%	-$41.1K	2.36%	10
2013 Q3	$3.26M	Buy	46,713 +240	+0.5%	+$15.7K	2.02%	12
2013 Q2	$2.69M	Buy	+46,473	New	+$2.69M	1.98%	15

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Financial Management Professionals's IBB Position: Q2 2023 in Review

Financial Management Professionals sold out of iShares Biotechnology ETF (IBB) in Q2 2023, closing a stake of 3 shares.

Financial Management Professionals first reported a position in IBB in Q2 2013 and held it in 14 quarters. The position peaked at $3.59M in Q1 2014. 843 funds tracked by Wall St. Rank hold IBB as of Q2 2023.

Financial Management Professionals reported no remaining iShares Biotechnology ETF position as of Q2 2023 after selling out during the quarter.
Financial Management Professionals sold 3 iShares Biotechnology ETF shares in Q2 2023.
Financial Management Professionals first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 14 quarters.
Financial Management Professionals's iShares Biotechnology ETF position peaked at $3.59M in Q1 2014.
843 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.

Based on Financial Management Professionals's 13F filing for Q2 2023, filed 10 Jul 2023.